This systematic review synthesizes the current landscape of artificial intelligence (AI) and machine learning (ML) applications for predicting and diagnosing male infertility.
This article provides a comprehensive guide for researchers and drug development professionals on the application of machine learning (ML) in the validation of predictive biomarkers.
This article provides researchers, scientists, and drug development professionals with a comprehensive framework for understanding, measuring, and optimizing concordance across next-generation sequencing (NGS) platforms.
Premature Ovarian Insufficiency (POI) represents a significant challenge in reproductive medicine, with genetic factors contributing to 20-25% of cases.
This article systematically compares the genetic architecture of Premature Ovarian Insufficiency (POI) presenting as primary versus secondary amenorrhea, addressing a critical knowledge gap in reproductive medicine.
Primary ovarian insufficiency (POI) affects 1-3.7% of women under 40, causing infertility and significant health implications.
This article provides a comprehensive guide for researchers and drug development professionals on constructing and optimizing bioinformatics pipelines for Primary Ovarian Insufficiency (POI) Next-Generation Sequencing (NGS) data.
Premature Ovarian Insufficiency (POI) is a genetically heterogeneous disorder, with over 70% of cases historically remaining idiopathic.
This article provides a comprehensive resource for researchers and clinicians investigating the genetic underpinnings of Primary Ovarian Insufficiency (POI) through copy number variation (CNV) analysis.
Premature Ovarian Insufficiency (POI), affecting 1-3.7% of women, remains idiopathic in a significant proportion of cases, posing a major challenge in female infertility.